Neonc Technologies Holdings, Inc. (NTHI) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

31/100

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

25

Expensive

Momentum

22

Weakening

Sentiment

64

Bullish

Risk resilience

34

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

Industry: Biotechnology
Sector: Healthcare
Headquarters: US
CEO: Amir Farrokh Heshmatpour
Listed since: Mar 26, 2025
Employees: 5

Market position

Day range

Current $4.675

$4.39$4.8899

52-week range

Current $4.675

$3.005$12.99

Open: $4.61
Previous close: $4.56
Volume: 167.74K; 1.29× average
Average volume: 130.21K; Average daily volume
Market cap: 121.23M USD
Beta: 0.5; Market reference 1
50-day average: $4.1281; +13.25% above average
200-day average: $6.8007; -31.26% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 165.14M USD
P/E (TTM): -2.11×
P/B (TTM): -6.22×
P/S (TTM): 0×
EV / EBITDA: -2.77×
Earnings yield: -39.11%
Free cash flow yield: -13.13%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 0.00%
Operating margin: 0.00%
Net margin: 0.00%
Return on equity: 354.96%
Return on assets: -2200.93%
Return on invested capital: 519.65%

Financial health

Debt / equity: -0.02×
Current ratio: 0.07×
Altman Z-score: -65.47
Piotroski F-score: 2 of 9

Financial statements

Metric (USD)	FY2025
Revenue	39.99K USD
Gross profit	39.99K USD
Research and development	3.64M USD
Selling, general, and administrative	42.85M USD
Operating expenses	58.21M USD
Interest income	327.58K USD
Interest expense	2.5M USD
Depreciation and amortization	36.46K USD
Operating income	−58.17M USD
Net income	−62.15M USD